Healthcare -
Biotechnology - NASDAQ - US
$ 1.63
3.82 %
$ 248 M
Market Cap
-10.19
P/E
HRTX - OPERATING INCOME
Operating Income HRTX - Heron Therapeutics, Inc.
-111 M
LAST VALUE
28.74%
2 YEAR CAGR
9.67%
5 YEAR CAGR
-7.34%
10 YEAR CAGR